Sionna Therapeutics (SION) Other Non Operating Income (2024 - 2025)
Sionna Therapeutics (SION) reported Other Non Operating Income of $71000.0 for Q3 2025, down 62.63% on a YoY basis from $190000.0 in Q3 2024, and down 58.48% sequentially from $171000.0 in Q2 2025.
Sionna Therapeutics (SION) Other Non Operating Income (2024 - 2025) Analysis & Trends
Sionna Therapeutics (SION) has 2 years of Other Non Operating Income data on file, last reported at $71000.0 in Q3 2025.
- For the quarter ending Q3 2025, Other Non Operating Income fell 62.63% year-over-year to $71000.0; the trailing twelve-month figure through Mar 2026 stood at $242000.0 (down 65.77% YoY), and the FY2025 full-year result was $419000.0, down 39.97% from the prior year.
- Other Non Operating Income fell to $71000.0 in Q3 2025, from $171000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $190000.0 in Q3 2024 to a low of $71000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Sionna Therapeutics | 1.98 Bn | 1.98 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 71,000.00 |
| Jun 30, 2025 | 171,000.00 |
| Mar 31, 2025 | 177,000.00 |
| Dec 31, 2024 | 166,000.00 |
| Sep 30, 2024 | 190,000.00 |
| Jun 30, 2024 | 174,000.00 |
| Mar 31, 2024 | 168,000.00 |